Home/Filings/4/0001179110-21-000561
4//SEC Filing

Lim Bryant David 4

Accession 0001179110-21-000561

CIK 0000861838other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 7:08 PM ET

Size

8.4 KB

Accession

0001179110-21-000561

Insider Transaction Report

Form 4
Period: 2021-01-08
Lim Bryant David
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2021-01-12$4.21/sh1,711$7,20238,064 total
  • Award

    Stock Option (Right to Buy)

    2021-01-08+51,00051,000 total
    Exercise: $4.28Exp: 2031-01-08Common Stock (51,000 underlying)
Footnotes (4)
  • [F1]Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 5,000 Restricted Stock Units ("RSUs") on January 10, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $4.1901 to $4.239 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Of the reported securities beneficially owned, 24,050 shares are represented by unvested RSUs.
  • [F4]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 8, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001752888

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 7:08 PM ET
Size
8.4 KB